Articles related to ANTITHROMBOTIC THERAPY

The study’s findings suggest a potential paradigm shift in the management of cancer patients with isolated distal DVT. With the 12-month edoxaban regimen reducing the occurrence of the primary composite endpoint to just 1.0% compared to 7.2% in the three-month group, this could represent a significant advancement in patient care.

Recent studies and guidelines are shifting the paradigm in coagulation management for cirrhosis patients undergoing low-risk procedures; discover why traditional markers like INR may not be reliable indicators of bleeding risk.

Dive into this intriguing case of a young woman presenting with right calf pain and an acute thrombosis. Join your peers in discerning the most appropriate therapeutic strategy, deepening your clinical acumen in the process.

The new recommendations include continuing antiplatelet therapy for patients with a baseline indication for it, starting dual antiplatelet therapy for patients with confirmed ACS, and adding prophylactic-dose LMWH for patients on antiplatelet therapy for a previous stroke.

Check out the updated guideline for changes prevention and treatment of VTE in a variety of cancer settings.

Because each patient reports unique challenges, there is no “one size fits all” approach to managing cancer-associated venous thrombosis (CAT). Thrombosis is a complication that HCPs are not recognizing early enough in the face of multiple options for appropriately treating and managing CAT; additionally, there is a lack of awareness of new CAT management clinical data. Although the morbidity and mortality of VTE in cancer patients remain high, unfortunately, its management is not given the same priority. And although recommendations suggest an individualized approach to managing these patients, clinical practice adoption is slow. Published guidelines and clinical trial data do not always correspond to real-world practice and prescribing practices. As a result, many existing CAT management protocols must be updated as new guidance is warranted.